Home › Therapeutic areas › Immunology › Crohn's Disease

Crohn's Disease (6 companies)

Companies with an active program in Crohn's Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ABVX Abivax Immunology 1 Phase 3 $7.19B 2
AGMB Agomab Therapeutics ImmunologyRespiratory Rare 1 Phase 2 $292M 4
PALI Palisade Bio Immunology 1 Phase 2 $181M 3
PTGX Protagonist Therapeutics DermatologyHematology+2 Rare 1 Approved $8.14B 12
SYRE Spyre Therapeutics DermatologyImmunology Rare 3 Phase 2 $8.91B 10
XNCR Xencor ImmunologyNeurology+1 Rare 2 Approved $2.59B 28